Close Menu

NEW YORK (GenomeWeb) – In a filing with US Securities and Exchange Commission today, CareDx said it has entered into an agreement with investment bank Jefferies to sell up to $50 million in shares of its common stock from time to time.

Jefferies, which is acting as CareDx's agent and underwriter in the sale, will be entitled to compensation at a commission rate of up to 3 percent of the gross sales price of the shares sold under the agreement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.